— Know what they know.
Not Investment Advice

DXCM NASDAQ

DexCom, Inc.
1W: +24.4% 1M: +13.4% 3M: -1.6% YTD: +8.1% 1Y: -17.7% 3Y: -39.4% 5Y: -13.7%
$72.10
+0.20 (+0.28%)
 
Weekly Expected Move ±6.1%
$54 $58 $62 $65 $69
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 74 · $27.8B mcap · 384M float · 1.26% daily turnover · Short 46% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
59.8 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 37.4%  ·  5Y Avg: 23.4%
Cost Advantage ★
75
Intangibles
41
Switching Cost
53
Network Effect
67
Scale
75
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. DXCM has a Narrow competitive edge (59.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Cost Advantage. ROIC of 37.4% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$64
Low
$78
Avg Target
$100
High
Based on 8 analysts since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 41Hold: 8Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$78.25
Analysts8
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-18 Canaccord Genuity $100 $82 -18 +33.1% $61.63
2026-05-18 Barclays Matt Miksic $67 $64 -3 +3.8% $61.63
2026-05-01 Bernstein $86 $77 -9 +26.2% $61.03
2026-05-01 Robert W. Baird $87 $80 -7 +29.4% $61.83
2026-05-01 Mizuho Securities Anthony Petrone $90 $75 -15 +21.7% $61.65
2026-05-01 Raymond James $101 $81 -20 +36.0% $59.55
2026-05-01 Canaccord Genuity $95 $100 +5 +67.9% $59.55
2026-05-01 Barclays $72 $67 -5 +12.5% $59.55
2026-02-13 Robert W. Baird $82 $87 +5 +23.1% $70.67
2026-02-13 Mizuho Securities Anthony Petrone $78 $90 +12 +38.3% $65.08
2026-02-13 Canaccord Genuity $99 $95 -4 +46.0% $65.08
2026-02-13 Barclays $71 $72 +1 +10.6% $65.08
2026-01-12 Barclays $80 $71 -9 +1.9% $69.67
2026-01-09 Bernstein $84 $86 +2 +25.7% $68.43
2025-12-17 Mizuho Securities Initiated $78 +17.5% $66.37
2025-12-16 Leerink Partners Mike Kratky $500 $92 -408 +40.7% $65.38
2025-12-02 Morgan Stanley Patrick Wood $63 $75 +12 +18.1% $63.52
2025-11-10 Morgan Stanley $131 $63 -68 +14.1% $55.21
2025-11-03 Bernstein Lee Hambright $105 $84 -21 +44.3% $58.22
2025-11-03 Barclays $113 $80 -33 +37.4% $58.22
2025-10-31 Piper Sandler Matt O'Brien $100 $75 -25 +31.6% $56.97
2025-10-31 RBC Capital $120 $85 -35 +49.3% $56.95
2025-10-31 Robert W. Baird $90 $82 -8 +38.5% $59.19
2025-10-31 Wells Fargo $575 $93 -482 +36.4% $68.20
2025-10-31 Canaccord Genuity William Plovanic $89 $99 +10 +45.2% $68.20
2025-10-21 Piper Sandler Matt O'Brien $90 $100 +10 +46.1% $68.44
2025-10-15 Truist Financial Richard Newitter Initiated $94 +43.4% $65.55
2025-09-26 Robert W. Baird Initiated $90 +31.8% $68.30
2024-10-08 RBC Capital Shagun Singh $130 $120 -10 +74.9% $68.62
2024-08-22 Stifel Nicolaus Mathew Blackman $132 $100 -32 +38.4% $72.28
2024-08-16 RBC Capital Shagun Singh $145 $130 -15 +79.7% $72.36
2024-07-29 Barclays Matt Miksic Initiated $113 +76.6% $64.00
2024-07-26 Oppenheimer Steven Lichtman $150 $115 -35 +6.6% $107.85
2024-07-26 Piper Sandler Matt O\'Brien $120 $90 -30 +42.4% $63.22
2024-07-26 Canaccord Genuity William Plovanic $625 $89 -536 -17.5% $107.85
2024-07-26 RBC Capital Shagun Singh $165 $145 -20 +356.4% $31.77
2024-07-12 Stifel Nicolaus Mathew Blackman $130 $132 +2 +17.2% $112.66
2024-06-03 Oppenheimer Steven Lichtman $122 $150 +28 +30.2% $115.23
2024-05-30 Redburn Partners Issie Kirby Initiated $130 +1.8% $127.64
2024-03-12 RBC Capital Shagun Singh Initiated $165 +22.7% $134.47
2023-10-27 Oppenheimer Steven Lichtman $580 $122 -458 +37.2% $88.91
2023-01-06 Morgan Stanley $83 $131 +48 +14.5% $114.45
2022-12-26 Stifel Nicolaus Stifel Stifel Initiated $130 +16.7% $111.44
2022-12-12 Citigroup $630 $146 -484 +25.2% $116.64
2022-10-07 Piper Sandler Matt O'Brien $110 $120 +10 +26.0% $95.21
2022-08-01 Raymond James $486 $101 -385 +23.1% $82.08
2022-07-29 Morgan Stanley $91 $83 -8 -4.6% $86.99
2022-07-28 Piper Sandler Matt O'Brien $480 $110 -370 +26.5% $86.99
2022-07-15 Bernstein Lee Hambright Initiated $105 +37.3% $76.50
2022-06-28 BTIG Marie Thibault $560 $105 -455 +37.1% $76.60

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
4
ROE
5
ROA
5
D/E
2
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. DXCM receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-02-13 B B+
2026-01-21 B+ B
2026-01-14 B B+
2026-01-12 B+ B
2026-01-09 B B+
2026-01-07 B+ B
2026-01-06 B B+
2026-01-05 B+ B
2026-01-03 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

81 Grade A+
Profitability
80
Balance Sheet
87
Earnings Quality
48
Growth
73
Value
33
Momentum
95
Safety
100
Cash Flow
92
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. DXCM scores highest in Safety (100/100) and lowest in Value (33/100). An overall grade of A+ places DXCM among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.40
Safe Zone
Piotroski F-Score
8/9
Beneish M-Score
-3.00
Unlikely Manipulator
Ohlson O-Score
-8.87
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 95.2/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 1.92x
Accruals: -13.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. DXCM scores 6.40, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DXCM scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DXCM's score of -3.00 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DXCM's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DXCM receives an estimated rating of AAA (score: 95.2/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). DXCM's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
29.84x
PEG
0.40x
P/S
5.77x
P/B
9.39x
P/FCF
17.29x
P/OCF
13.87x
EV/EBITDA
16.74x
EV/Revenue
5.00x
EV/EBIT
20.41x
EV/FCF
16.87x
Earnings Yield
3.76%
FCF Yield
5.78%
Shareholder Yield
2.17%
Graham Number
$19.26
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 29.8x earnings, DXCM commands a growth premium. Graham's intrinsic value formula yields $19.26 per share, 274% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.773
NI / EBT
×
Interest Burden
1.019
EBT / EBIT
×
EBIT Margin
0.245
EBIT / Rev
×
Asset Turnover
0.751
Rev / Assets
×
Equity Multiplier
2.645
Assets / Equity
=
ROE
38.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DXCM's ROE of 38.4% is driven by Asset Turnover (0.751), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
50.10%
Fair P/E
108.71x
Intrinsic Value
$256.97
Price/Value
0.24x
Margin of Safety
75.56%
Premium
-75.56%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with DXCM's realized 50.1% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $256.97, DXCM appears undervalued with a 76% margin of safety. The adjusted fair P/E of 108.7x compares to the current market P/E of 29.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$72.10
Median 1Y
$72.67
5th Pctile
$33.64
95th Pctile
$157.19
Ann. Volatility
49.2%
Analyst Target
$78.25
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Kevin Sayer
Executive Chairman
$1,213,515 $13,853,723 $16,282,598
Jacob Leach &
resident & Chief Executive Officer
$768,962 $5,936,062 $7,985,960
Jereme Sylvain EVP,
Chief Financial Officer
$646,623 $5,936,062 $7,077,902
Jon Coleman EVP,
Chief Commercial Officer
$491,507 $5,831,045 $6,745,295
Michael Brown EVP,
Chief Legal Officer
$631,627 $5,242,495 $6,343,856
Sadie Stern EVP,
Chief Human Resources Officer
$571,209 $5,242,495 $6,253,131

CEO Pay Ratio

69:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,985,960
Avg Employee Cost (SGA/emp): $116,306
Employees: 11,100

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
11,100
+15.6% YoY
Revenue / Employee
$420,000
Rev: $4,662,000,000
Profit / Employee
$75,342
NI: $836,300,000
SGA / Employee
$116,306
Avg labor cost proxy
R&D / Employee
$53,973
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 39.2% 39.1% 8.0% 10.9% 10.3% 11.9% 16.3% 14.0% 17.1% 18.1% 25.8% 30.4% 31.8% 32.4% 27.6% 25.7% 27.4% 34.6% 34.5% 38.4% 38.38%
ROA 15.9% 15.8% 3.4% 4.6% 4.3% 5.0% 6.6% 5.7% 6.9% 7.3% 9.3% 11.0% 11.4% 11.7% 9.0% 8.4% 9.0% 11.3% 13.0% 14.5% 14.51%
ROIC 71.6% 72.3% 15.9% 19.3% 17.2% 17.2% 18.8% 15.2% 17.5% 17.5% 23.5% 27.6% 29.1% 29.6% 23.1% 22.0% 23.7% 27.7% 32.8% 37.4% 37.38%
ROCE 9.6% 10.1% 6.6% 6.5% 6.0% 6.7% 11.5% 12.3% 14.7% 17.4% 15.5% 17.0% 17.5% 16.2% 20.5% 21.1% 22.6% 27.5% 25.8% 28.1% 28.14%
Gross Margin 70.1% 68.7% 67.7% 63.3% 64.6% 64.2% 66.4% 62.4% 62.7% 63.9% 63.5% 61.0% 62.4% 59.7% 58.9% 56.9% 59.5% 60.5% 62.9% 62.9% 62.95%
Operating Margin 17.0% 18.2% 0.1% 6.6% 11.1% 19.2% 15.4% 6.4% 14.7% 21.1% 21.0% 11.0% 15.7% 15.3% 17.0% 12.9% 18.4% 20.1% 25.6% 21.4% 21.42%
Net Margin 10.6% 10.9% -2.8% 15.5% 7.3% 13.1% 11.3% 6.6% 13.3% 12.4% 24.8% 15.9% 14.3% 13.5% 13.6% 10.2% 15.5% 23.5% 21.2% 16.7% 16.74%
EBITDA Margin 21.1% 22.1% 6.2% 12.5% 17.8% 24.7% 21.4% 14.9% 24.0% 30.1% 29.3% 20.6% 24.4% 23.9% 24.6% 21.1% 26.7% 34.8% 30.8% 27.0% 27.05%
FCF Margin 4.6% 6.0% 2.2% 3.7% 8.1% 9.4% 10.5% 13.8% 14.6% 14.7% 14.1% 15.3% 16.9% 13.5% 15.6% 13.9% 13.3% 23.5% 23.1% 29.7% 29.67%
OCF Margin 18.8% 21.9% 18.1% 18.9% 22.3% 23.0% 23.0% 24.9% 24.1% 22.0% 20.7% 21.1% 22.7% 20.8% 24.5% 23.2% 23.0% 32.1% 30.9% 37.0% 37.00%
ROE 3Y Avg snapshot only 30.08%
ROE 5Y Avg snapshot only 22.87%
ROA 3Y Avg snapshot only 11.04%
ROIC 3Y Avg snapshot only 26.21%
ROIC Economic snapshot only 19.78%
Cash ROA snapshot only 28.12%
Cash ROIC snapshot only 83.41%
CROIC snapshot only 66.89%
NOPAT Margin snapshot only 16.58%
Pretax Margin snapshot only 24.98%
R&D / Revenue snapshot only 12.44%
SGA / Revenue snapshot only 27.62%
SBC / Revenue snapshot only 3.50%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 85.93 111.14 336.68 259.06 157.27 149.10 141.35 166.23 155.11 105.62 95.31 90.41 70.86 40.39 54.89 52.00 62.35 38.04 31.66 26.57 29.843
P/S Ratio 21.01 25.36 21.27 21.32 11.75 12.28 16.57 16.09 17.34 11.70 14.25 15.20 12.01 6.95 7.84 6.71 8.28 6.07 5.68 5.13 5.775
P/B Ratio 24.96 32.21 25.51 26.86 15.38 16.79 22.62 22.81 26.01 18.68 24.95 27.94 22.84 13.29 15.04 13.24 16.95 13.04 9.64 9.00 9.390
P/FCF 453.66 421.69 977.21 579.74 145.74 131.24 158.28 116.88 119.00 79.67 100.82 99.05 71.01 51.40 50.15 48.38 62.42 25.82 24.58 17.29 17.293
P/OCF 111.47 115.64 117.71 112.92 52.62 53.35 72.04 64.49 71.88 53.28 68.95 72.04 53.01 33.47 31.96 28.86 36.08 18.93 18.38 13.87 13.867
EV/EBITDA 102.46 125.34 135.81 138.91 79.28 77.50 84.65 80.72 80.64 50.18 56.16 57.92 45.69 28.06 33.45 28.55 34.30 22.43 19.35 16.74 16.742
EV/Revenue 20.61 24.99 21.04 21.10 11.53 12.07 16.47 15.98 17.24 11.61 14.21 15.17 11.98 6.92 7.84 6.71 8.29 6.07 5.55 5.00 5.004
EV/EBIT 126.59 155.76 185.76 198.94 122.89 118.99 116.82 110.35 105.43 63.98 70.45 72.20 57.05 35.88 43.46 37.12 44.38 28.04 23.84 20.41 20.412
EV/FCF 445.02 415.47 966.45 573.68 143.08 129.05 157.26 116.13 118.33 79.05 100.56 98.83 70.81 51.16 50.16 48.39 62.44 25.82 24.01 16.87 16.867
Earnings Yield 1.2% 0.9% 0.3% 0.4% 0.6% 0.7% 0.7% 0.6% 0.6% 0.9% 1.0% 1.1% 1.4% 2.5% 1.8% 1.9% 1.6% 2.6% 3.2% 3.8% 3.76%
FCF Yield 0.2% 0.2% 0.1% 0.2% 0.7% 0.8% 0.6% 0.9% 0.8% 1.3% 1.0% 1.0% 1.4% 1.9% 2.0% 2.1% 1.6% 3.9% 4.1% 5.8% 5.78%
PEG Ratio snapshot only 0.397
Price/Tangible Book snapshot only 9.324
EV/OCF snapshot only 13.525
EV/Gross Profit snapshot only 8.136
Acquirers Multiple snapshot only 23.330
Shareholder Yield snapshot only 2.17%
Graham Number snapshot only $19.26
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 5.58 5.58 5.11 5.11 5.11 5.11 1.99 1.99 1.99 1.99 2.84 2.84 2.84 2.84 1.47 1.47 1.47 1.47 1.88 1.88 1.883
Quick Ratio 5.19 5.19 4.62 4.62 4.62 4.62 1.83 1.83 1.83 1.83 2.48 2.48 2.48 2.48 1.28 1.28 1.28 1.28 1.59 1.59 1.589
Debt/Equity 1.01 1.01 1.06 1.06 1.06 1.06 1.01 1.01 1.01 1.01 1.25 1.25 1.25 1.25 1.23 1.23 1.23 1.23 0.51 0.51 0.506
Net Debt/Equity -0.48 -0.48 -0.28 -0.28 -0.28 -0.28 -0.15 -0.15 -0.15 -0.15 -0.06 -0.06 -0.06 -0.06 0.00 0.00 0.00 0.00 -0.22 -0.22 -0.222
Debt/Assets 0.43 0.43 0.44 0.44 0.44 0.44 0.40 0.40 0.40 0.40 0.41 0.41 0.41 0.41 0.40 0.40 0.40 0.40 0.22 0.22 0.219
Debt/EBITDA 4.21 3.98 5.69 5.52 5.55 4.96 3.79 3.58 3.14 2.72 2.83 2.61 2.52 2.66 2.74 2.65 2.49 2.12 1.04 0.97 0.965
Net Debt/EBITDA -1.99 -1.88 -1.51 -1.47 -1.47 -1.32 -0.55 -0.52 -0.46 -0.40 -0.14 -0.13 -0.13 -0.13 0.01 0.01 0.01 0.01 -0.46 -0.42 -0.423
Interest Coverage 6.04 9.61 14.75 13.99 12.93 14.61 21.14 23.54 26.41 30.72 36.00 39.34 43.03 40.15 38.32 39.26 42.27 51.47 59.28 86.85 86.846
Equity Multiplier 2.35 2.35 2.42 2.42 2.42 2.42 2.53 2.53 2.53 2.53 3.03 3.03 3.03 3.03 3.08 3.08 3.08 3.08 2.31 2.31 2.309
Cash Ratio snapshot only 0.933
Debt Service Coverage snapshot only 105.882
Cash to Debt snapshot only 1.438
FCF to Debt snapshot only 1.029
Defensive Interval snapshot only 622.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.65 0.69 0.53 0.56 0.58 0.61 0.56 0.59 0.62 0.66 0.62 0.65 0.68 0.68 0.63 0.65 0.67 0.71 0.73 0.75 0.751
Inventory Turnover 3.78 4.02 2.59 2.83 3.06 3.31 3.09 3.24 3.47 3.70 3.08 3.26 3.39 3.50 2.89 3.05 3.22 3.36 3.18 3.17 3.166
Receivables Turnover 6.07 6.49 5.19 5.46 5.67 5.92 4.74 4.92 5.21 5.54 4.29 4.51 4.66 4.69 4.07 4.19 4.35 4.56 4.20 4.34 4.337
Payables Turnover 5.04 5.36 4.35 4.75 5.14 5.55 4.81 5.03 5.40 5.75 5.19 5.50 5.70 5.89 5.13 5.41 5.71 5.95 5.39 5.38 5.379
DSO 60 56 70 67 64 62 77 74 70 66 85 81 78 78 90 87 84 80 87 84 84.2 days
DIO 97 91 141 129 119 110 118 113 105 99 119 112 108 104 126 120 113 109 115 115 115.3 days
DPO 72 68 84 77 71 66 76 73 68 63 70 66 64 62 71 67 64 61 68 68 67.9 days
Cash Conversion Cycle 84 79 127 119 113 106 119 114 108 101 133 126 122 120 145 139 133 127 134 132 131.6 days
Fixed Asset Turnover snapshot only 2.943
Operating Cycle snapshot only 199.5 days
Cash Velocity snapshot only 2.411
Capital Intensity snapshot only 1.316
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 26.5% 27.4% 27.1% 26.9% 23.2% 20.4% 18.8% 17.5% 19.6% 21.8% 24.5% 25.8% 23.1% 16.2% 11.3% 9.1% 9.3% 14.2% 15.6% 16.1% 16.15%
Net Income 1.6% 1.3% -68.7% -58.8% -62.4% -56.5% 1.2% 38.2% 79.0% 63.9% 58.7% 1.2% 86.5% 80.6% 6.4% -16.3% -14.3% 5.9% 45.1% 73.8% 73.84%
EPS 1.4% 1.1% -68.5% -59.8% -61.9% -56.1% 1.0% 41.6% 74.8% 63.5% 62.5% 1.2% 93.1% 87.9% 8.8% -14.4% -12.5% 6.6% 48.0% 80.0% 79.98%
FCF -51.9% -47.2% -80.7% -59.9% 1.1% 87.3% 4.7% 3.4% 1.2% 91.3% 68.0% 40.3% 42.8% 7.0% 23.2% -1.4% -14.2% 98.5% 70.8% 1.5% 1.49%
EBITDA 32.2% 23.5% 0.7% -0.6% -10.9% -5.9% 49.2% 53.2% 75.8% 80.9% 61.9% 66.3% 50.8% 23.9% 3.2% -2.1% 0.8% 25.3% 41.3% 47.7% 47.68%
Op. Income 33.3% 24.3% -11.3% -16.2% -31.2% -27.8% 47.2% 52.0% 89.0% 90.0% 52.8% 64.1% 52.1% 24.1% 0.4% -2.9% 0.8% 23.8% 52.0% 63.4% 63.36%
OCF Growth snapshot only 84.89%
Asset Growth snapshot only -2.23%
Equity Growth snapshot only 30.60%
Debt Growth snapshot only -46.29%
Shares Change snapshot only -3.41%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 37.6% 36.4% 33.4% 31.6% 29.8% 27.4% 25.4% 23.6% 23.1% 23.2% 23.4% 23.3% 21.9% 19.5% 18.1% 17.3% 17.2% 17.4% 17.0% 16.8% 16.81%
Revenue 5Y 34.7% 34.2% 33.7% 33.8% 33.4% 33.1% 32.3% 31.8% 30.9% 30.1% 28.6% 27.5% 26.4% 24.0% 22.3% 21.0% 20.2% 19.9% 19.3% 18.9% 18.91%
EPS 3Y 1.2% 43.3% 21.2% 16.2% 15.0% 0.9% 7.7% 8.8% 10.5% 52.6% 38.6% 43.5% 48.5% 37.8% 50.1% 50.10%
EPS 5Y 49.2% 39.1% 27.3% 21.6% 25.0% 10.6% 14.0% 13.99%
Net Income 3Y 1.3% 50.0% 25.5% 20.4% 17.7% 3.1% 7.5% 7.9% 8.8% 55.0% 36.2% 42.0% 46.3% 34.8% 47.1% 47.07%
Net Income 5Y 54.2% 41.6% 29.3% 22.8% 25.5% 11.1% 12.6% 12.60%
EBITDA 3Y 1.0% 65.0% 38.5% 31.1% 27.5% 28.1% 34.5% 36.3% 33.2% 28.2% 35.6% 35.6% 38.8% 41.1% 33.2% 34.0% 34.00%
EBITDA 5Y 1.8% 67.6% 50.2% 34.7% 29.7% 25.8% 26.7% 28.8% 29.7% 29.66%
Gross Profit 3Y 39.5% 39.3% 36.3% 34.4% 32.1% 29.0% 26.4% 24.1% 23.1% 22.2% 21.4% 20.4% 18.0% 14.9% 13.2% 12.4% 12.7% 13.7% 14.2% 15.0% 15.01%
Gross Profit 5Y 35.7% 35.4% 34.7% 34.3% 32.7% 31.9% 30.8% 30.4% 29.9% 29.6% 28.1% 27.3% 26.3% 23.6% 21.2% 19.3% 18.2% 17.5% 17.0% 16.7% 16.73%
Op. Income 3Y 40.1% 27.8% 20.1% 19.5% 25.9% 27.9% 25.5% 19.4% 31.2% 34.3% 42.6% 42.9% 32.6% 37.5% 37.55%
Op. Income 5Y 33.3% 27.2% 21.6% 21.2% 24.9% 27.1% 27.08%
FCF 3Y 23.5% 29.9% -1.7% 21.6% 76.6% 72.5% 31.3% 47.1% 30.6% 23.6% 22.8% 35.2% 87.8% 56.5% 1.3% 82.5% 38.4% 59.6% 52.3% 50.9% 50.90%
FCF 5Y 65.5% 98.7% 1.5% 63.6% 76.0% 54.2% 51.0% 55.6% 61.8% 76.3% 60.1% 36.2% 34.5% 22.3% 32.1% 31.2% 43.4% 43.37%
OCF 3Y 54.9% 57.3% 53.1% 50.1% 53.0% 46.5% 28.6% 35.3% 25.1% 18.7% 16.3% 17.0% 29.7% 17.3% 30.8% 25.7% 18.3% 31.1% 29.1% 33.2% 33.22%
OCF 5Y 52.8% 56.5% 51.1% 53.7% 63.6% 58.6% 48.7% 55.5% 47.6% 41.7% 43.5% 41.1% 39.8% 32.1% 25.8% 25.9% 20.2% 26.5% 24.8% 28.9% 28.87%
Assets 3Y 68.0% 68.0% 37.1% 37.1% 37.1% 37.1% 31.1% 31.1% 31.1% 31.1% 13.4% 13.4% 13.4% 13.4% 9.5% 9.5% 9.5% 9.5% 5.5% 5.5% 5.55%
Assets 5Y 71.2% 71.2% 65.0% 65.0% 65.0% 65.0% 42.9% 42.9% 42.9% 42.9% 26.7% 26.7% 26.7% 26.7% 22.0% 22.0% 22.0% 22.0% 8.1% 8.1% 8.12%
Equity 3Y 63.3% 63.3% 45.5% 45.5% 45.5% 45.5% 34.2% 34.2% 34.2% 34.2% 4.2% 4.2% 4.2% 4.2% 1.0% 1.0% 1.0% 1.0% 8.8% 8.8% 8.81%
Book Value 3Y 53.9% 54.0% 41.2% 37.4% 38.6% 38.8% 28.2% 29.5% 29.5% 31.1% 2.0% 4.4% 5.1% 5.9% -0.6% 2.7% 2.1% 2.5% 11.2% 11.1% 11.05%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.95 0.96 0.97 0.98 0.99 0.99 1.00 1.00 1.00 1.00 0.99 0.99 0.99 1.00 0.99 0.99 0.99 1.00 1.00 0.99 0.993
Earnings Stability 0.58 0.56 0.49 0.57 0.49 0.49 0.53 0.49 0.48 0.47 0.61 0.60 0.62 0.64 0.51 0.41 0.42 0.57 0.55 0.50 0.501
Margin Stability 0.96 0.96 0.97 0.97 0.96 0.96 0.96 0.97 0.97 0.97 0.97 0.97 0.96 0.95 0.95 0.95 0.96 0.96 0.96 0.95 0.952
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.85 0.50 0.50 0.50 0.50 0.50 0.50 0.97 0.93 0.94 0.98 0.82 0.50 0.500
Earnings Smoothness 0.11 0.22 0.00 0.17 0.09 0.21 0.25 0.68 0.43 0.52 0.55 0.26 0.40 0.43 0.94 0.82 0.85 0.94 0.63 0.46 0.461
ROE Trend 0.30 0.29 -0.12 -0.12 -0.16 -0.16 -0.01 -0.06 -0.03 -0.02 0.14 0.19 0.19 0.18 0.06 0.03 0.03 0.09 0.04 0.06 0.057
Gross Margin Trend 0.06 0.05 0.04 0.02 -0.00 -0.02 -0.03 -0.03 -0.04 -0.03 -0.03 -0.03 -0.02 -0.03 -0.03 -0.04 -0.05 -0.04 -0.02 0.00 0.004
FCF Margin Trend -0.03 -0.03 -0.10 -0.06 -0.00 -0.01 0.02 0.06 0.08 0.07 0.08 0.07 0.06 0.02 0.03 -0.01 -0.02 0.09 0.08 0.15 0.151
Sustainable Growth Rate 39.2% 39.1% 8.0% 10.9% 10.3% 11.9% 16.3% 14.0% 17.1% 18.1% 25.8% 30.4% 31.8% 32.4% 27.6% 25.7% 27.4% 34.6% 34.5% 38.4% 38.38%
Internal Growth Rate 18.9% 18.8% 3.5% 4.8% 4.5% 5.2% 7.1% 6.0% 7.4% 7.9% 10.2% 12.3% 12.9% 13.2% 9.9% 9.2% 9.8% 12.7% 15.0% 17.0% 16.97%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.77 0.96 2.86 2.29 2.99 2.79 1.96 2.58 2.16 1.98 1.38 1.25 1.34 1.21 1.72 1.80 1.73 2.01 1.72 1.92 1.916
FCF/OCF 0.25 0.27 0.12 0.19 0.36 0.41 0.46 0.55 0.60 0.67 0.68 0.73 0.75 0.65 0.64 0.60 0.58 0.73 0.75 0.80 0.802
FCF/Net Income snapshot only 1.536
OCF/EBITDA snapshot only 1.238
CapEx/Revenue 14.2% 15.9% 15.9% 15.2% 14.3% 13.7% 12.5% 11.2% 9.6% 7.3% 6.5% 5.8% 5.7% 7.3% 8.9% 9.4% 9.7% 8.6% 7.8% 7.3% 7.33%
CapEx/Depreciation snapshot only 1.364
Accruals Ratio 0.04 0.01 -0.06 -0.06 -0.09 -0.09 -0.06 -0.09 -0.08 -0.07 -0.04 -0.03 -0.04 -0.02 -0.06 -0.07 -0.07 -0.11 -0.09 -0.13 -0.133
Sloan Accruals snapshot only 0.041
Cash Flow Adequacy snapshot only 5.048
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 2.4% 1.6% 1.9% 2.1% 50.1% 1.3% 1.1% 75.0% 1.8% 1.3% 1.4% 1.3% 26.0% 59.8% 57.6% 57.59%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 1.6% 1.2% 1.1% 1.3% 0.5% 1.3% 1.2% 1.1% 4.5% 2.4% 2.7% 2.1% 0.7% 1.9% 2.2% 2.17%
Net Buyback Yield -0.0% -0.0% -0.0% -0.0% -0.1% 1.6% 1.1% 1.1% 1.3% 0.4% 1.3% 1.1% 1.0% 4.4% 2.3% 2.6% 2.0% 0.6% 1.8% 2.1% 2.06%
Total Shareholder Return -0.0% -0.0% -0.0% -0.0% -0.1% 1.6% 1.1% 1.1% 1.3% 0.4% 1.3% 1.1% 1.0% 4.4% 2.3% 2.6% 2.0% 0.6% 1.8% 2.1% 2.06%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.93 1.82 0.80 1.01 1.07 0.95 0.87 0.70 0.71 0.63 0.76 0.82 0.83 0.92 0.81 0.73 0.73 0.75 0.77 0.77 0.773
Interest Burden (EBT/EBIT) 0.78 0.78 0.70 0.77 0.75 0.86 0.95 0.96 0.96 0.97 0.97 0.97 0.98 0.98 0.97 0.97 0.98 0.98 1.00 1.02 1.019
EBIT Margin 0.16 0.16 0.11 0.11 0.09 0.10 0.14 0.14 0.16 0.18 0.20 0.21 0.21 0.19 0.18 0.18 0.19 0.22 0.23 0.25 0.245
Asset Turnover 0.65 0.69 0.53 0.56 0.58 0.61 0.56 0.59 0.62 0.66 0.62 0.65 0.68 0.68 0.63 0.65 0.67 0.71 0.73 0.75 0.751
Equity Multiplier 2.47 2.47 2.38 2.38 2.38 2.38 2.47 2.47 2.47 2.47 2.78 2.78 2.78 2.78 3.06 3.06 3.06 3.06 2.64 2.64 2.645
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $1.24 $1.23 $0.40 $0.49 $0.47 $0.54 $0.80 $0.70 $0.83 $0.88 $1.30 $1.53 $1.60 $1.66 $1.42 $1.31 $1.40 $1.77 $2.10 $2.36 $2.36
Book Value/Share $4.28 $4.24 $5.26 $4.76 $4.85 $4.80 $5.01 $5.09 $4.94 $4.99 $4.97 $4.96 $4.96 $5.04 $5.17 $5.16 $5.15 $5.16 $6.88 $6.98 $7.68
Tangible Book/Share $4.18 $4.15 $5.11 $4.63 $4.71 $4.66 $4.54 $4.62 $4.48 $4.53 $4.59 $4.58 $4.58 $4.65 $4.86 $4.85 $4.84 $4.85 $6.65 $6.74 $6.74
Revenue/Share $5.08 $5.39 $6.31 $6.00 $6.34 $6.56 $6.83 $7.22 $7.41 $7.97 $8.71 $9.12 $9.44 $9.64 $9.92 $10.18 $10.54 $11.08 $11.69 $12.24 $12.51
FCF/Share $0.24 $0.32 $0.14 $0.22 $0.51 $0.61 $0.72 $0.99 $1.08 $1.17 $1.23 $1.40 $1.60 $1.30 $1.55 $1.41 $1.40 $2.61 $2.70 $3.63 $3.71
OCF/Share $0.96 $1.18 $1.14 $1.13 $1.42 $1.51 $1.57 $1.80 $1.79 $1.75 $1.80 $1.93 $2.14 $2.00 $2.43 $2.37 $2.42 $3.55 $3.61 $4.53 $4.63
Cash/Share $6.34 $6.29 $7.04 $6.37 $6.48 $6.41 $5.77 $5.87 $5.69 $5.75 $6.55 $6.54 $6.54 $6.64 $6.34 $6.33 $6.32 $6.33 $5.01 $5.08 $6.27
EBITDA/Share $1.02 $1.07 $0.98 $0.91 $0.92 $1.02 $1.33 $1.43 $1.58 $1.84 $2.20 $2.39 $2.47 $2.38 $2.33 $2.39 $2.55 $3.00 $3.35 $3.66 $3.66
Debt/Share $4.31 $4.27 $5.56 $5.03 $5.12 $5.07 $5.04 $5.13 $4.97 $5.03 $6.24 $6.23 $6.22 $6.32 $6.36 $6.35 $6.34 $6.35 $3.48 $3.53 $3.53
Net Debt/Share $-2.03 $-2.02 $-1.48 $-1.34 $-1.36 $-1.35 $-0.73 $-0.74 $-0.72 $-0.73 $-0.31 $-0.31 $-0.31 $-0.32 $0.02 $0.02 $0.02 $0.02 $-1.53 $-1.55 $-1.55
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 6.397
Altman Z-Prime snapshot only 11.682
Piotroski F-Score 6 6 6 5 6 6 6 7 6 6 8 8 8 8 7 6 6 8 8 8 8
Beneish M-Score -0.49 -0.54 -2.43 -2.37 -2.53 -2.52 -2.16 -2.29 -2.21 -2.19 -2.28 -2.27 -2.35 -2.25 -2.62 -2.61 -2.61 -2.85 -2.78 -3.00 -3.001
Ohlson O-Score snapshot only -8.870
ROIC (Greenblatt) snapshot only 33.48%
Net-Net WC snapshot only $1.12
EVA snapshot only $585132967.76
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AAA
Credit Score 75.05 78.70 78.24 78.25 80.37 83.05 84.87 83.36 84.87 85.84 88.01 88.15 88.77 88.10 83.97 83.59 84.12 85.89 93.40 95.20 95.201
Credit Grade snapshot only 1
Credit Trend snapshot only 11.608
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 91
Sector Credit Rank snapshot only 91

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms